Article

Colonoscopy Prep Made Palatable

Author(s):

Patients recommended for screening colonoscopy often resist because the bowel cleansing regimen is unpleasant. In an abstract presented at the 2015 Digestive Disease Week conference in Washington, DC, Campbell Levy, MD, of Dartmouth-Hitchcock Medical Center in Lebanon, NH, and colleagues at other institutions reported on a novel edible product that achieves the desired results.

Patients recommended for screening colonoscopy often resist because the bowel cleansing regimen is unpleasant.

In an abstract presented May 17 at the 2015 Digestive Disease Week conference in Washington, DC, Campbell Levy, MD, of Dartmouth-Hitchcock Medical Center in Lebanon, NH, and colleagues at other institutions report on a novel edible product that achieves the desired results.

In addition to being unpopular with patients, the colonoscopy prep products now in use can be up to 25% ineffective, the team wrote.

“Poor taste and the large volume required are significant impediments to adequate cleansing, resulting in about 5% to 15% of patients not being able to complete the entire preparation,” they said.

Further, studies have confirmed that fear of the preparation is the main reason patients avoid screening.

The new product is a mix of meals, snacks and drinks blended with PEG 3350, sorbitol, an ascorbic acid.

Ten patients with a median age of 61 were enrolled and the study was halted because all of them “had a successful colon cleansing.”

Even 2 who did not consume 100% of the products consumed 95%.

The definition of “excellent” results was “no more than small bits of adherent feces or fluid” and the definition of “good” was a large volume of clear to semiclear liquid.”

Nine patients had a good global assessment of the preparation and 1 an excellent. There were no adverse events and all 10 gave the regimen a score of 1 on a 1-to-5 score where a low number meant the diet was tolerable with no problems.

The team concluded the regimen is feasible, effective, and safe.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.